| Authors: |
Scialli AR; Reproductive Toxicology Center and Scialli Consulting LLC, Washington, DC., Daston G; Proctor & Gamble, Mason, Ohio., Chen C; ILSI Health and Environmental Sciences Institute, Washington, DC., Coder PS; Charles River Laboratories, Ashland, Ohio., Euling SY; Office of Children's Health Protection, U.S. Environmental Protection Agency, Washington, DC., Foreman J; ExxonMobil Biomedical Sciences, Inc, Annandale, New Jersey., Hoberman AM; Charles River Laboratories, Horsham, Pennsylvania., Hui J; Celgene Corporation, Summit, New Jersey., Knudsen T; National Center for Computational Toxicology, U.S. Environmental Protection Agency, Research Triangle Park, North Carolina., Makris SL; National Center for Environmental Assessment, U.S. Environmental Protection Agency, Washington, DC., Morford L; Lilly Research Laboratories, Indianapolis, Indiana., Piersma AH; Center for Health Protection, National Institute for Public Health and the Environment RIVM, Bilthoven and Institute for Risk Assessment Sciences, Utrecht University, Utrecht, Netherlands., Stanislaus D; GlaxoSmithKline, King of Prussia, Pennsylvania., Thompson KE; Drug Safety Evaluation, Bristol-Myers Squibb, New Brunswick, New Jersey. |
